[Extrasystole - a widespread phenomenon].

Introduction: Background: Extrasystole is a common reason for visits to general practitioners. In cardiological literature, supraventricular extrasystole in particular tends to play a minor role. This article discusses the current state of knowledge and common practice for this frequently encountered clinical problem. Question: Due to increasing health awareness among the population and the use of new diagnostic technologies (e.g. smartwatches), there has been an increase in GP consultations among young and healthy patients with symptomatic or asymptomatic extrasystole. Comorbidities play a decisive role in this clinical picture. This review provides an overview of supraventricular and ventricular extrasystoles and explicitly addresses the question of diagnostic and therapeutic approaches in the context of extrasystoles in healthy young people. Methodology: A targeted literature search was conducted in the PubMed, EMBASE, Cochrane and Library databases using the search terms: Extrasystole, supraventricular extrasystoles, ventricular extrasystoles, arrhythmia, tachycardia, ambulatory ECG monitoring, premature ventricular complex (PVC), premature atrial complex (PAC), heart rate variability, Holter ECG monitoring, taking into account the current guidelines of the European Society of Cardiology (ESC). Results: 54 publications were identified, the results of which were evaluated in line with the research question. From these, the key conclusions for general practitioners dealing with this issue were drawn. Conclusion: In principle, technological improvements and wider accessibility among the population lead to increased use of diagnostic procedures. According to the latest findings, it is important for primary care providers to note that even asymptomatic SVES - although in principle harmless when isolated - should not be ignored. Early detection and monitoring of individuals with frequent SVES in combination with cardiovascular risk factors could help reduce the risk of cardiovascular events, including strokes and other complications associated with atrial fibrillation. With regard to ventricular extrasystoles, it should be noted that asymptomatic individuals with a low VES burden of  5 % do not require further investigation. Antiarrhythmic therapy plays a purely symptomatic role in the treatment of extrasystoles and has no prognostic benefit. Catheter ablation has become increasingly important in recent years and is the first-line treatment for symptomatic, idiopathic ventricular extrasystoles from the RVOT and left bundle branch in the current ESC guidelines from 2022.